Incretins
Showing 26 - 50 of 252
Type 2 Diabetes, Obesity Trial in Rochester (procedure, behavioral, drug)
Completed
- Type 2 Diabetes Mellitus
- Obesity
- Roux-en-Y Gastric Bypass (RYGB)
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 5, 2022
Obesity, Inflammatory Markers, Glycemic Variation Trial in New York (Time restricted feeding arm, usual feeding pattern arm)
Recruiting
- Obesity
- +4 more
- Time restricted feeding arm
- usual feeding pattern arm
-
New York, New YorkThe Rockefeller University Hospital
Jun 22, 2022
Diabetes, Bariatric Surgery Candidate Trial in Ramat Gan (Continuous Glucose monitoring in the perioperative period)
Withdrawn
- Diabetes Mellitus
- Bariatric Surgery Candidate
- Continuous Glucose monitoring in the perioperative period
-
Ramat Gan, Tel Aviv (Gosh Dan), IsraelSheba Medical Center
Oct 3, 2021
Long-term Health After Severe Acute Malnutrition in Children and
Recruiting
- Pancreas Atrophy
- +2 more
- no interventions will be used
-
Delhi, India
- +3 more
Apr 29, 2022
Postprandial Hypoglycemia, Age-Related Memory Disorders Trial in Aberdeen (Honeyberry, Cherry, Raspberry)
Recruiting
- Postprandial Hypoglycemia
- Age-Related Memory Disorders
- Honeyberry
- +2 more
-
Aberdeen, United KingdomRowett Research Institute, University of Aberdeen
Aug 23, 2022
SGLT2 Inhibitors on Cognitive Functions and BDNF Levels in Type
Terminated
- Type2 Diabetes
- Cognitive Impairment
- MOCA cognitive evaluation test
- +3 more
-
Istanbul, TurkeyIstanbul Medeniyet University Goztepe Research and Training Hosp
Apr 16, 2022
Physiologic and Functional Adaptations of Insulin Sensitive
Enrolling by invitation
- Diabetes
- +5 more
- Endoscopy biopsy
- +3 more
-
Nashville, TennesseeVanderbilt University Medical Center
Nov 29, 2021
Cardiovascular Diseases Trial in Leiden (Mixed meal test)
Recruiting
- Cardiovascular Diseases
- Mixed meal test
-
Leiden, NetherlandsLeiden University Medical Center
Apr 12, 2023
Glucose Tolerance Trial in New York (Tyrosine (TYR) Supplementation)
Completed
- Glucose Tolerance
- Tyrosine (TYR) Supplementation
-
New York, New YorkColumbia University Irving Medical Center
Apr 30, 2021
Type 2 Diabetes, Insulin Resistance Trial in Minneapolis (Gastric Bypass w/ matched hypocaloric diet, Hypocaloric diet)
Active, not recruiting
- Type 2 Diabetes Mellitus
- Insulin Resistance
- Gastric Bypass w/ matched hypocaloric diet
- Hypocaloric diet
-
Minneapolis, MinnesotaUniversity of Minnesota
Sep 7, 2021
Type 2 Diabetes Trial in Odense (Hydrolyzed pine nut oil)
Completed
- Type 2 Diabetes Mellitus
- Hydrolyzed pine nut oil
-
Odense, DenmarkDepartment of Endocrinology
Dec 11, 2018
Insulin Sensitivity/Resistance Trial in Mexico City (Sucralose, Placebo)
Unknown status
- Insulin Sensitivity/Resistance
- Sucralose
- Placebo
-
Mexico City, MexicoInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubi
Feb 8, 2021
Healthy, Hypercholesterolemia Trial in Madrid (Olive pomace oil, Sunflower oil)
Completed
- Healthy
- Hypercholesterolemia
- Olive pomace oil
- Sunflower oil
-
Madrid, SpainInstituto de Ciencia y Tecnología de Alimentos y Nutrición
Aug 9, 2021
Healthy, Hypercholesterolemia Trial in Madrid (Olive pomace oil, High oleic acid sunflower oil)
Completed
- Healthy
- Hypercholesterolemia
- Olive pomace oil
- High oleic acid sunflower oil
-
Madrid, SpainInstituto de Ciencia y Tecnología de Alimentos y Nutrición
Aug 8, 2021
Glucose Intolerance, Overweight and Obesity, Drug Effect Trial in Houston (Dulaglutide, Cyanocobalamin)
Recruiting
- Glucose Intolerance
- +3 more
-
Houston, TexasThe University of Texas Health Science Center at Houston
Jun 2, 2021
Diabetes, Type 2 Trial in Aarhus N (Fermented aronia, Aronia, Placebo)
Active, not recruiting
- Diabetes Mellitus, Type 2
- Fermented aronia
- +2 more
-
Aarhus N, Danmark, DenmarkAarhus University Hospital
Mar 11, 2022
Prediabetes Trial in Blacksburg (Cocoa, Placebo)
Completed
- Prediabetes
- Cocoa
- Placebo
-
Blacksburg, VirginiaHuman Integrative Physiology Laboratory
Sep 20, 2021
Type2 Diabetes Trial in Hellerup (Placebo, GIP receptor antagonization)
Active, not recruiting
- Type2 Diabetes
- Placebo
- GIP receptor antagonization
-
Hellerup, Capital Region, DenmarkCenter for Clinical Metabolic Research, Gentofte Hospital
Sep 16, 2021
Overweight/Obesity, Insulin Resistance Trial in Madrid (Green coffee extract, Beta glucan, Green coffee + beta-glucan)
Completed
- Overweight/Obesity
- Insulin Resistance
- Green coffee extract
- +2 more
-
Madrid, SpainInstituto de Ciencia y Tecnología de Alimentos y Nutrición
Aug 11, 2021
Type2 Diabetes Trial in Columbia (No exercise, Morning exercise, Evening exercise)
Completed
- Type2 Diabetes
- No exercise
- +2 more
-
Columbia, MissouriUniversity of Missouri
Oct 13, 2021
Type2 Diabetes, Diabetes, Diabetes, Type 2 Trial in Worldwide (Tirzepatide Dose 1, Tirzepatide Dose 2, Placebo)
Recruiting
- Type2 Diabetes
- +7 more
- Tirzepatide Dose 1
- +2 more
-
Birmingham, Alabama
- +55 more
Aug 8, 2022
Type 2 Diabetes Trial in Dundee (Sulfonylurea, DPP4 Inhibitor)
Completed
- Type 2 Diabetes
- Sulfonylurea
- DPP4 Inhibitor
-
Dundee, United KingdomNinewells Hospital and Medical School
Mar 3, 2021
Type 2 Diabetes Trial in Marseille, Paris (1: incretin-based therapy, 2: other antidiabetic)
Recruiting
- Type 2 Diabetes
- 1: incretin-based therapy
- 2: other antidiabetic
-
Marseille, France
- +1 more
Jul 5, 2021
Diabetes, Type 2, Metabolic Syndrome Trial in Potsdam (Intervention A, Intervention B, Intervention C)
Completed
- Diabetes Mellitus, Type 2
- Metabolic Syndrome
- Intervention A
- +3 more
-
Potsdam, Brandenburg, GermanyGerman Institute of Human Nutrition
Jun 23, 2020
Type II Diabetes Trial in Dijon (drug, procedure, other)
Recruiting
- Type II Diabetes
- GLP-1 agonists
- +2 more
-
Dijon, FranceChu Dijon Bourgogne
Jan 2, 2023